Halozyme Therapeutics Inc (HALO)
61.84
-1.97
(-3.09%)
USD |
NASDAQ |
Apr 01, 16:00
61.87
+0.03
(+0.05%)
After-Hours: 20:00
Halozyme Therapeutics Total Assets (Quarterly): 2.063B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.989B |
| Johnson & Johnson | 180.10B |
| Catalyst Pharmaceuticals Inc | 851.41M |
| Merck & Co Inc | 117.11B |
| Semler Scientific Inc | 239.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.700B |
| Shareholders Equity (Quarterly) | 363.82M |
| Debt to Equity Ratio | 4.139 |
| Current Ratio | 7.803 |
| Net Debt Paydown Yield | -0.03% |